Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
PubMed PMID: 23721803
Formula: C17H14N2O3
Giannetti AM
fortuitum at 16 and 0
(R)-roscovitine
SQ109 Size:Solid 2 mg PubMed PMID: 23721803SQ109 is a drug undergoing development for treatment of tuberculosis. SQ109 showed activity against both drug susceptible and Multi drug resistant tuberculosis bacteria, including Extensively drug resistant tuberculosis strains. In preclinical studies SQ109 enhanced the activity of anti tubercular drugs isoniazid and rifampin and reduced by >30% the time required to cure mice of experimental TB. SQ109 is being developed by OOO Infectex in Russia and
US$ 2594.00
US$ 137.50
US$ 55.00
US$ 129.00
US$ 175.00
US$ 169.00
US$ 155.00
US$ 181.00
US$ 158.00
US$ 185.00